Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Explore conversion timing for a two-earner couple, including tax impact, income thresholds, and optimal years to convert for long-term growth.
18,272 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
At age 65, Health Savings Accounts shift from a pure medical fund to a hybrid tool that can rival a 401(k) for non-me...
Memory chips are the quiet engine behind AI growth. The shocking 1,290% surge in sandisk stock over the past year sig...
As UnitedHealth gears up for its July 16 results, traders focus on pricing power and rising cash flow as the main rea...
From AI tools reshaping research to currency risk and the tug of timing, the Rule Breaker Investing Mailbag surfaces ...
When high-profile dating rumors grab headlines, it’s a wake-up call on money, privacy, and personal branding. This pi...
A federal judge sent Nevada's cases against Kalshi and Polymarket back to state court, opening the door for temporary...
Fermi America slumped 11.5% as it unveiled a $375 million convertible note offering and reported a Q1 with zero reven...
Kontoor Brands posted Q4 2025 results with revenue above $1B and a solid earnings beat, driven by a key acquisition. ...
A wave of U.S. retirees is moving to Greece, living on roughly $2,800 a month as they navigate visas, healthcare, and...
Rhode Island unveils a sweeping rhode island housing package aimed at speeding development, loosening zoning and park...
July 2026 brings a fresh wave of opportunities in semiconductors. This guide reveals five names with durable demand, ...